1 

2 

Free writing prospectus statement

This presentation highlights basic information about us and the offering to which this communication relates. Because it is a summary, it does not contain all of the information that you should consider before investing in our securities.  

We have filed a registration statement (including a prospectus, which currently is in preliminary form) with the U.S. Securities and Exchange Commission, or the SEC, for the offering to which this presentation relates. The registration has not yet become effective. Before you invest, you should read the preliminary prospectus in the registration statement (including the risk factors described therein) and other documents we have filed with the SEC for more complete information about us and this offering.  

You may access these documents for free by visiting EDGAR on the SEC Web site at www.sec.gov.  

The preliminary prospectus, dated March 20, 2017, is available on the SEC Web site at https://www.sec.gov/Archives/edgar/data/1618500/000121390017002624/ff12017a1_medigusltd.htm.  

Alternatively, we or the placement agent participating in the offering will arrange to send you the preliminary prospectus and, when available, the final prospectus and/or any supplements thereto if you contact H.C. Wainwright & Co., LLC, 430 Park Avenue, New York, New York 10022, via e-mail at placements@hcwco.com or via telephone at (212) 356-0530.

 

 

3 

 

4 

5 

6 

7 

8 

9 

10 

11 

12 

13 

14 

15 

16 

17 

18 

19 

20 

21 

22 

23 

24 

25 

26 

27 

28